Safety in Aflibercept versus Ranibizumab

Saved in:
Bibliographic Details
Published inOphthalmology (Rochester, Minn.) Vol. 121; no. 1; p. e5
Main Author Ueta, Takashi, MD, PhD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 2014
Subjects
Female
Humans
Male
Ophthalmology
Recombinant Fusion Proteins - therapeutic use
Wet Macular Degeneration - drug therapy
Online AccessGet full text

Cover

Author Ueta, Takashi, MD, PhD
Author_xml – sequence: 1
  fullname: Ueta, Takashi, MD, PhD
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24256894$$D View this record in MEDLINE/PubMed
BookMark eNqFkctOwzAQRS0EouXxBwh12U3C-BE33iChipdUCYnH2rKdiXBIk2InSOXrSRVgwYbVbM6d0T1zRPabtkFCziikFKi8qNJ289q9mpQB5SmoFKjaI1OaCZWIBeX7ZDpgNJGCwYQcxVgBgJRcHJIJEyyTuRJTMn8yJXbbmW9mV2XtLQaHm272gSH2cfZoGm_9Z7829oQclKaOePo9j8nLzfXz8i5ZPdzeL69WieOcdYk0ee4Ac5YXRpXSFmAVt5lz1uUZCsYzuWCFzUrEQkFmpVJKuJIOlUrlZM6PyXzcuwnte4-x02sfHda1abDto6ZCwUJmjMGAihF1oY0xYKk3wa9N2GoKeudIV3p0pHeONCg9OBpi598XervG4jf0I2UALkcAh54fHoOOzmPjsPABXaeL1v934e8CV_vGO1O_4RZj1fahGRxqqiPToJ92f9q9iXKAnKsF_wIqm49J
CitedBy_id crossref_primary_10_1517_14740338_2014_939951
crossref_primary_10_1517_14740338_2014_911284
crossref_primary_10_1111_jcpt_12278
crossref_primary_10_21561_jor_2016_1_1_11
crossref_primary_10_1007_s10384_015_0374_4
crossref_primary_10_1016_j_ophtha_2014_05_022
Cites_doi 10.1016/j.ophtha.2012.09.006
10.1097/IAE.0b013e31825db6ba
10.1016/j.ophtha.2008.09.046
ContentType Journal Article
Copyright American Academy of Ophthalmology
2014 American Academy of Ophthalmology
Copyright_xml – notice: American Academy of Ophthalmology
– notice: 2014 American Academy of Ophthalmology
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.ophtha.2013.09.019
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1549-4713
EndPage e5
ExternalDocumentID 10_1016_j_ophtha_2013_09_019
24256894
S0161642013008397
1_s2_0_S0161642013008397
Genre Letter
Comment
Commentary
Correspondence
GroupedDBID ---
--K
.1-
.55
.FO
.GJ
0R~
123
1B1
1P~
1~5
29N
4.4
457
4G.
53G
5RE
5VS
7-5
71M
AAEDT
AAEDW
AALRI
AAQFI
AAQQT
AAQXK
AAXUO
ABCQX
ABFRF
ABJNI
ABLJU
ABMAC
ABOCM
ACGFO
ACGFS
ACIUM
ACNCT
ADMUD
ADPAM
AEFWE
AENEX
AEVXI
AFFNX
AFJKZ
AFRHN
AFTJW
AITUG
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BELOY
C5W
CS3
DU5
EBS
EFJIC
EJD
F5P
FDB
FEDTE
FGOYB
GBLVA
HVGLF
HZ~
IHE
J1W
K-O
KOM
L7B
M27
M41
MO0
N4W
N9A
NQ-
O9-
OF-
OPF
OQ~
P2P
R2-
RIG
ROL
RPZ
SDG
SEL
SES
SSZ
UHS
UNMZH
UV1
WH7
X7M
XH2
XPP
Z5R
ZGI
ZXP
AAIAV
AGZHU
AHPSJ
ALXNB
ZA5
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c332t-6a88c0e828da9f6bd0b93b5ccbc85e4235672db5feed905b69994cf1101f9c683
ISSN 0161-6420
IngestDate Fri Aug 16 03:58:54 EDT 2024
Thu Sep 26 16:15:28 EDT 2024
Sat Sep 28 08:47:09 EDT 2024
Fri Feb 23 02:14:11 EST 2024
Tue Oct 15 22:54:46 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c332t-6a88c0e828da9f6bd0b93b5ccbc85e4235672db5feed905b69994cf1101f9c683
Notes SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
PMID 24256894
PQID 1490765220
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1490765220
crossref_primary_10_1016_j_ophtha_2013_09_019
pubmed_primary_24256894
elsevier_sciencedirect_doi_10_1016_j_ophtha_2013_09_019
elsevier_clinicalkeyesjournals_1_s2_0_S0161642013008397
PublicationCentury 2000
PublicationDate 2014
January 2014
2014-Jan
2014-01-00
20140101
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – year: 2014
  text: 2014
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Ophthalmology (Rochester, Minn.)
PublicationTitleAlternate Ophthalmology
PublicationYear 2014
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Ueta, Yanagi, Tamaki, Yamaguchi (bib2) 2009; 116
Heier, Brown, Chong (bib1) 2012; 119
Accessed January 2, 2013.
Safety on Lucentis. Available at
Bressler, Boyer, Williams (bib4) 2012; 32
VEGF Trap-Eye (aflibercept ophthalmic solution) Briefing Document. Available at
Accessed January 4, 2013.
23084240 - Ophthalmology. 2012 Dec;119(12):2537-48
24536092 - Ophthalmology. 2014 Jan;121(1):e5-e6
10.1016/j.ophtha.2013.09.019_bib3
Heier (10.1016/j.ophtha.2013.09.019_bib1) 2012; 119
Ueta (10.1016/j.ophtha.2013.09.019_bib2) 2009; 116
10.1016/j.ophtha.2013.09.019_bib5
Bressler (10.1016/j.ophtha.2013.09.019_bib4) 2012; 32
References_xml – volume: 116
  start-page: 362
  year: 2009
  ident: bib2
  article-title: Cerebrovascular accidents in ranibizumab
  publication-title: Ophthalmology
  contributor:
    fullname: Yamaguchi
– volume: 119
  start-page: 2537
  year: 2012
  end-page: 2548
  ident: bib1
  article-title: Intravitreal aflibercept (VEGF Trap-Eye) in wet age-related macular degeneration
  publication-title: Ophthalmology
  contributor:
    fullname: Chong
– volume: 32
  start-page: 1821
  year: 2012
  end-page: 1828
  ident: bib4
  article-title: Cerebrovascular accidents in patients treated for choroidal neovascularization with ranibizumab in randomized controlled trials
  publication-title: Retina
  contributor:
    fullname: Williams
– volume: 119
  start-page: 2537
  year: 2012
  ident: 10.1016/j.ophtha.2013.09.019_bib1
  article-title: Intravitreal aflibercept (VEGF Trap-Eye) in wet age-related macular degeneration
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2012.09.006
  contributor:
    fullname: Heier
– volume: 32
  start-page: 1821
  year: 2012
  ident: 10.1016/j.ophtha.2013.09.019_bib4
  article-title: Cerebrovascular accidents in patients treated for choroidal neovascularization with ranibizumab in randomized controlled trials
  publication-title: Retina
  doi: 10.1097/IAE.0b013e31825db6ba
  contributor:
    fullname: Bressler
– volume: 116
  start-page: 362
  year: 2009
  ident: 10.1016/j.ophtha.2013.09.019_bib2
  article-title: Cerebrovascular accidents in ranibizumab
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2008.09.046
  contributor:
    fullname: Ueta
– ident: 10.1016/j.ophtha.2013.09.019_bib3
– ident: 10.1016/j.ophtha.2013.09.019_bib5
SSID ssj0006634
Score 2.1853611
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage e5
SubjectTerms Female
Humans
Male
Ophthalmology
Recombinant Fusion Proteins - therapeutic use
Wet Macular Degeneration - drug therapy
Title Safety in Aflibercept versus Ranibizumab
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0161642013008397
https://dx.doi.org/10.1016/j.ophtha.2013.09.019
https://www.ncbi.nlm.nih.gov/pubmed/24256894
https://search.proquest.com/docview/1490765220
Volume 121
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdbCmMvY91ntnV4sIdBUVBsWbYeSz8oC92gTVjfhCTLNN3qlNl56V-_k08ODlno1hcTG8U-308fvzvfnQj5nMH4YdxZCou58N4qQWUqHXWS8wR6WMnaYs9n38TpjH-9TC-7jbZDdkljRvbur3klD0EVrgGuPkv2P5Bd3RQuwG_AF46AMBz_CeMLXfqIS--yKNs4ER-jsu8DLZb1_rmu5mZ-t7zRps9Av99eNVf61w3WXmodCGHPLIyir6pRzzswc8gup_qn33WpbXKEjpijvsMAUzQ776EYUzA42Nr0hxnKazjjZObS3rKIJxsTLtr-16NFK7wPlUvaurFhHlyrb318OBnTOh4xeuEl8YL4j2lA0bL1xmidqDpWTG00fUx2Yl_Ub0B2DibnPyardRe4U6jkji_ZJUq20Xyb8m0jItsMjZZwTJ-TZ8FSiA4Q9l3yyFUvyJOzEAvxknxB9KN5FfXQjxD9qIf-KzI7OZ4entKw7wW1SRI3VOg8t8yBLVxoWQpTMCMTk1prbJ464L-pyOLCpCXwG8lSI4Dkc1vCoBuX0oo8eU0G1aJyb0nEhDGxNVpzWXCT6Jxzy3Vi4tIUjnExJLRTgrrF8iaqi_u7Vqg05ZWmmFSgtCHJOk2pLnUXFhtXh1FRq22w9f8ZyB2SNgVd6Z5nfuogUTD3-Q9aunKLJTyLS5YJsCDYkLxBrFZv4U1pkUv-7sESvydP_fBBf9sHMmh-L90eMNDGfAxd7w9MQX6a
link.rule.ids 315,783,787,4033,27937,27938,27939
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Safety+in+Aflibercept+versus+Ranibizumab&rft.jtitle=Ophthalmology+%28Rochester%2C+Minn.%29&rft.au=Ueta%2C+Takashi%2C+MD%2C+PhD&rft.date=2014&rft.issn=0161-6420&rft.volume=121&rft.issue=1&rft.spage=e5&rft.epage=e5&rft_id=info:doi/10.1016%2Fj.ophtha.2013.09.019&rft.externalDBID=ECK1-s2.0-S0161642013008397&rft.externalDocID=1_s2_0_S0161642013008397
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01616420%2FS0161642013X00119%2Fcov150h.gif